These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 3361753

  • 21. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats.
    Abe H, Shibuya T, Odashima S, Arichi S, Nagase S.
    Nephron; 1988; 50(4):351-5. PubMed ID: 3237275
    [Abstract] [Full Text] [Related]

  • 22. Study of anionic sites on the mesangium in aminonucleoside nephrosis.
    Ueda Y, Wada N, Hirabayashi K, Ono H, Iidaka K.
    Nihon Jinzo Gakkai Shi; 1989 Oct; 31(10):1001-9. PubMed ID: 2615011
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of glomerular visceral epithelial cell endocytosis during nephrosis induced by puromycin aminonucleoside.
    Schwartz MM, Sharon Z, Pauli BU, Lewis EJ.
    Lab Invest; 1984 Dec; 51(6):690-6. PubMed ID: 6389977
    [Abstract] [Full Text] [Related]

  • 24. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y, Shirato I, Maeda A, Kobayashi N, Liao J, Shou I, Fukui M, Tomino Y.
    J Nephrol; 2002 Dec; 15(1):36-41. PubMed ID: 11936424
    [Abstract] [Full Text] [Related]

  • 25. Caffeine augments proteinuria in puromycin-aminonucleoside nephrotic rats.
    Tofovic SP, Rominski BR, Bastacky S, Jackso EK, Kost CK.
    Ren Fail; 2000 Mar; 22(2):159-79. PubMed ID: 10803761
    [Abstract] [Full Text] [Related]

  • 26. Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation.
    Diamond JR, Karnovsky MJ.
    Kidney Int; 1987 Nov; 32(5):671-7. PubMed ID: 3430956
    [Abstract] [Full Text] [Related]

  • 27. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study.
    Diamond JR, Pesek I.
    Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206
    [Abstract] [Full Text] [Related]

  • 28. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
    Wang JS, Yang AH, Chen SM, Young TK, Chiang H, Liu HC.
    Nephron; 1993 Jan; 65(3):418-25. PubMed ID: 8289993
    [Abstract] [Full Text] [Related]

  • 29. Focal and segmental glomerulosclerosis following a single intravenous dose of puromycin aminonucleoside.
    Diamond JR, Karnovsky MJ.
    Am J Pathol; 1986 Mar; 122(3):481-7. PubMed ID: 3953770
    [Abstract] [Full Text] [Related]

  • 30. Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury.
    Diamond JR, Pesek I, Ruggieri S, Karnovsky MJ.
    Am J Physiol; 1989 Nov; 257(5 Pt 2):F798-807. PubMed ID: 2589483
    [Abstract] [Full Text] [Related]

  • 31. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH, Boggs KP, Burke FC.
    Int J Pediatr Nephrol; 1985 Nov; 6(2):117-20. PubMed ID: 4030221
    [Abstract] [Full Text] [Related]

  • 32. Localization and distribution of anionic charges in the glomerular mesangium of normal and nephrotic rats.
    Grond J, Elema JD.
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1985 Nov; 48(2):135-43. PubMed ID: 2581361
    [Abstract] [Full Text] [Related]

  • 33. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
    Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY.
    Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817
    [Abstract] [Full Text] [Related]

  • 34. Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivative.
    Daniel C, Ziswiler R, Frey B, Pfister M, Marti HP.
    Exp Nephrol; 2000 Feb 28; 8(1):52-62. PubMed ID: 10644883
    [Abstract] [Full Text] [Related]

  • 35. Low molecular weight heparin in the treatment of puromycin-induced nephrosis.
    Dos Santos AM, de Olveira AV, da Silva Lemos CC, Mandarim-de-Lacerda CA, Bregman R.
    Pathol Res Pract; 2006 Feb 28; 202(3):157-63. PubMed ID: 16492522
    [Abstract] [Full Text] [Related]

  • 36. Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats.
    Shibouta Y, Terashita Z, Imura Y, Shino A, Kawamura M, Ohtsuki K, Ohkawa S, Nishikawa K, Fujiwara Y.
    Kidney Int; 1991 May 28; 39(5):920-9. PubMed ID: 2067208
    [Abstract] [Full Text] [Related]

  • 37. A morphometric, biochemical and histochemical comparison of puromycin aminonucleoside and hyperalbuminaemic induced proteinurias in the female Wistar rat.
    Lawrence GM, Brewer DB.
    J Pathol; 1983 Feb 28; 139(2):115-40. PubMed ID: 6827398
    [Abstract] [Full Text] [Related]

  • 38. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats.
    Nakamura T, Kimura K, Ebihara I, Takahashi T, Tomino Y, Aikawa M, Yazaki Y, Nagai R, Koide H.
    Clin Sci (Lond); 1995 Jul 28; 89(1):45-52. PubMed ID: 7671567
    [Abstract] [Full Text] [Related]

  • 39. Unilateral renal disease in the rat. II. Glomerular mesangial uptake of colloidal carbon in unilateral aminonucleoside nephrosis and nephrotoxic serum nephritis.
    Hoyer JR, Elema JD, Vernier RL.
    Lab Invest; 1976 Mar 28; 34(3):250-5. PubMed ID: 1082531
    [Abstract] [Full Text] [Related]

  • 40. Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin.
    Abboud HE, Ou SL, Velosa JA, Shah SV, Dousa TP.
    J Clin Invest; 1982 Feb 28; 69(2):327-36. PubMed ID: 7056851
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.